Not all inflammation is the same.

When most people hear the word inflammation, they think of a swollen ankle or the redness around a cut. That is acute inflammation — one of the most elegant and essential processes in human biology. A threat is detected, the immune system mobilises, the threat is neutralised, and the system returns to baseline. Without this process, minor infections would be fatal. Wounds would not heal. The human species would not have survived.

Chronic low-grade inflammation is something entirely different. It is invisible. It produces no obvious swelling, no localised pain, no temperature. It operates below the threshold of clinical detection in routine blood tests. And it is now understood to be the underlying driver of virtually every major chronic disease of the modern world — cardiovascular disease, type 2 diabetes, Alzheimer's, cancer, depression, and autoimmune conditions.

The critical difference is resolution. Acute inflammation resolves. Chronic inflammation does not. It persists — driven by diet, stress, sleep disruption, environmental exposures, and gut dysbiosis — creating a continuous low-level activation of the immune system that gradually damages tissues, accelerates biological aging, and impairs virtually every physiological system it touches.

What chronic inflammation actually does to your body.

The primary biomarkers of systemic inflammation — C-reactive protein (CRP), interleukin-6 (IL-6), and tumour necrosis factor-alpha (TNF-α) — are produced by the liver and immune cells in response to inflammatory signals from throughout the body. In acute inflammation, these spike dramatically and resolve within days. In chronic low-grade inflammation, they remain persistently elevated at moderate levels — too low to trigger clinical alarm, but high enough to continuously damage arterial walls, impair insulin signalling, disrupt brain function, and accelerate cellular aging.

The 2025 American College of Cardiology Scientific Statement on inflammation and cardiovascular risk described chronic low-grade inflammation as "an independent, modifiable risk factor for major cardiovascular events" — placing it alongside blood pressure and cholesterol as a primary target for intervention. This was a landmark shift in clinical thinking: inflammation is not just a marker of disease — it is a cause.

What is actually driving your inflammation.

Chronic inflammation does not arise from a single cause. It is a convergence of lifestyle, environmental, and biological factors that cumulatively tip the immune system into sustained activation. Understanding which drivers are most active for you is the first step to an effective anti-inflammatory strategy.

How to recognise chronic inflammation in your own body.

The challenge with chronic low-grade inflammation is that it rarely announces itself with a single dramatic symptom. It manifests as a constellation of seemingly unrelated experiences — fatigue, joint stiffness, skin conditions, digestive disruption, mood changes, and brain fog — that are each individually easy to dismiss, but collectively represent a coherent physiological state.

Joint stiffness and aching — particularly in the morning or after periods of inactivity — is one of the most consistent physical signs of systemic inflammation. The stiffness reflects overnight accumulation of inflammatory mediators in joint fluid, and its resolution over 30–60 minutes of movement is a characteristic pattern.

Skin conditions — eczema, psoriasis, rosacea, and adult acne — are increasingly understood as cutaneous manifestations of systemic inflammation, driven through the gut-skin axis. The skin is often the first organ where chronic inflammation becomes visible, particularly in people with compromised gut barrier function.

Persistent fatigue — the kind that sleep does not resolve — is one of the most common and underrecognised presentations of chronic inflammation. IL-6 and TNF-α directly impair mitochondrial function, reducing cellular energy production at the biochemical level. This is not tiredness. It is metabolic impairment driven by immune activation.

Brain fog and mood changes — difficulty concentrating, low motivation, and persistent low mood without clear psychological cause are increasingly recognised as neuroinflammatory symptoms. The concept of "sickness behaviour" — the cognitive and emotional changes that accompany immune activation — is well-established in research and directly relevant to the low-grade inflammation that characterises modern chronic stress.

What the evidence actually supports.

The most important insight from the inflammation research of the last decade is that anti-inflammatory intervention is most effective when it addresses multiple drivers simultaneously. Single-variable approaches — taking one supplement, eliminating one food — produce modest and inconsistent results because they address one input of a multi-driver system. Comprehensive lifestyle intervention, targeting diet, stress, sleep, movement, and gut health together, produces the most consistent and durable reductions in inflammatory markers.

Diet — the highest-leverage single variable. The Mediterranean dietary pattern has the strongest and most consistent clinical evidence for CRP reduction — with multiple RCTs showing 20–30% reductions in inflammatory markers within 12 weeks. The active components are omega-3 fatty acids (fatty fish, walnuts, flaxseed), polyphenols (diverse vegetables, berries, olive oil), and dietary fibre from varied plant sources. The most impactful single change is reducing ultra-processed food — its replacement with whole foods has measurable inflammatory benefits regardless of other dietary choices.

Movement — consistent, moderate, anti-inflammatory. Regular moderate exercise consistently reduces CRP, IL-6, and TNF-α across multiple study designs. The mechanism involves both direct anti-inflammatory effects — through myokine release during muscle contraction — and indirect effects through visceral fat reduction, improved insulin sensitivity, and enhanced gut microbiome diversity. The key is consistency and moderate intensity: high-intensity exercise in untrained individuals transiently elevates inflammation before producing benefits.

Stress regulation — addressing the cortisol-inflammation paradox. For people with significant chronic stress, stress management is not a secondary consideration — it is the primary anti-inflammatory intervention. Breathwork, yoga, and meditation reduce inflammatory markers through vagal activation and HPA axis downregulation. Multiple RCTs show significant reductions in IL-6 and CRP with consistent practice over 8 weeks.

Sleep optimisation — protecting the nightly reset. Improving sleep quality — through circadian consistency, stress reduction, and sleep environment optimisation — directly reduces inflammatory markers. The overnight anti-inflammatory repair process depends on adequate, well-timed, architecturally intact sleep. Each hour of chronic sleep debt has a measurable inflammatory cost.

Targeted supplementation with practitioner guidance. Omega-3 fatty acids (EPA and DHA at 2–4g daily) have the strongest clinical evidence for CRP and IL-6 reduction among supplements — with effect sizes comparable to statin therapy in high-CRP populations. Curcumin, resveratrol, and specific probiotic strains also have clinical evidence, though the appropriate protocol varies significantly by individual. Naturopathic and Ayurvedic practitioners have the most developed clinical frameworks for anti-inflammatory supplementation — integrating dietary, herbal, and lifestyle interventions in personalised protocols.